Sidley’s Global Life Sciences team invites you to our three-part series on clinical trials in San Diego. This series is for biotech and life sciences companies exploring cutting-edge developments and seeking practical regulatory guidance on successfully navigating global clinical trial design, execution, and collaboration considerations.
Part I: U.S. Clinical Trial Design & Execution Risks | January 29, 2026
Explore the key regulatory, enforcement, operational, and contractual risks shaping today’s clinical trial landscape in the U.S., including FDA expectations and emerging compliance challenges.
Part II: Clinical Trials & Collaborations | March 12, 2026
Examine the important implications of collaboration and licensing agreements on clinical trials, and tips for negotiating.
Part III: Global Trial Expansion — Key Considerations for EU/U.S. Sponsors | April 21, 2026
Explore how the EU and U.S. regulations impact global study planning and execution. Learn what U.S. sponsors should consider when transitioning between EU and U.S. for early-stage clinical trials to ensure compliance and accelerate development.
CLE credit for this series is pending.
